Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Is the global equity rally broadening? UBS weighs in
• Myriad Uranium completes acquisition of Rush Rare Metals